About Us
We are National Healthcare.
National Healthcare is one of the leading pharmaceutical companies of Nepal paving the path for the total care of people’s health.
WE ARE GROWING.
Our Marketing Divisions
The specialists at National Healthcare make efforts to provide best pharmaceutical solutions to ensure your complete care of your health.
Our MIlestones
How we grew up and expanded as today with trust and confidence built up from happy customers and harmony cooperation from partners.
1996 - Establishment
1996/04/10: Establishment of National Healthcare.
1998 - 1st Marketing of National Healthcare
Marketed Oral Liquid (Niko Suspension)
Marketed Oral Cephalosporin (Nedroxyl Dry Syrup)
Marketed Oral Penicillin (Nemox Dry Syrup)
Marketed Oral Cephalosporin (Nedroxyl Dry Syrup)
Marketed Oral Penicillin (Nemox Dry Syrup)
1998 - Product Launch
Launched Tablet (Niko Tablet)
Launched Capsule (Gloron Capsule). Marketed Oral Penicillin (Nemox Dry Syrup)
Launched Capsule (Gloron Capsule). Marketed Oral Penicillin (Nemox Dry Syrup)
2003 - Added Product Line
Marketed External Preparation (Nevidine100 ml).
2005 - Production Facility
Establishment of Sterile Plant.
2005 - Added Product Line
10/07/2007: Marketed Eye Drop (Dexafen Eye Drops 5 ml)
28/11/2007: Marketed Ear Drop (Chloro Ear Drops 5 ml)
03/01/2007: Marketed Small Volume Parenteral (SVP) (Hybro 1 ml Injection)
28/11/2007: Marketed Ear Drop (Chloro Ear Drops 5 ml)
03/01/2007: Marketed Small Volume Parenteral (SVP) (Hybro 1 ml Injection)
2010 - Added Cardiac & Anti-diabetic Products
07/07/2010: Marketed first Cardiac Product (Camlo 2.5, 5 and 10 mg Tablets)
16/11/2010: Marketed first Anti-diabetic Product (Netformin 500 and 850 mg Tablets)
16/11/2010: Marketed first Anti-diabetic Product (Netformin 500 and 850 mg Tablets)
2010 - Added Cardiac & Anti-diabetic Products
07/07/2010: Marketed first Cardiac Product (Camlo 2.5, 5 and 10 mg Tablets)
16/11/2010: Marketed first Anti-diabetic Product (Netformin 500 and 850 mg Tablets)
16/11/2010: Marketed first Anti-diabetic Product (Netformin 500 and 850 mg Tablets)
2013 - Added Product Line
Marketed Cephalosporin Dry Powder for Injection (DPI) (Stacef 1 gm)
2014 - Added Product Line
20/03/2014: Marketed Super-CV 375 Tablet
Marketed Super-CV 625 Tablet
08/07/2014: Marketed Super-CV BID 30 ml Dry Syrup
25/04/2014: Marketed Super-CV 1.2 gm. Dry Powder for Injection
Marketed Super-CV 625 Tablet
08/07/2014: Marketed Super-CV BID 30 ml Dry Syrup
25/04/2014: Marketed Super-CV 1.2 gm. Dry Powder for Injection
2016 - Added Product Line + Production Facility
10/02/2016: Marketed Piperacillin + Tazobactam Dry Powder for Injection
(Tazolin 2.25 &Tazolin 4.5)
20/06/2016: Establishment of Lyophilized Plant
(Tazolin 2.25 &Tazolin 4.5)
20/06/2016: Establishment of Lyophilized Plant
2017 - Intorduced the first lyophilized produc
Marketed the first Lyophilized product Vanesco-500
(Vancomycin 500 mg Lyophilized Injection)
(Vancomycin 500 mg Lyophilized Injection)
2020 - Added Product Line
01/2020: Marketed Benzathine Penicillin 600000 & 1200000 Units Dry Powder for Injection
(Rheuza-6 & Rheuze-12)
03/2020: Marketed DabigatranCapsules (Dabirom)
(Rheuza-6 & Rheuze-12)
03/2020: Marketed DabigatranCapsules (Dabirom)
2021 - New Product Launch
04/2021: Marketed Levetiracetam 100mg /ml Injection (Levetor)
05/2021: Marketed Ticagrelor Tablets (Ticalor 60 &Ticalor 90)
06/2021: Launched Remdesivir Injection (Remsivir)
05/2021: Marketed Ticagrelor Tablets (Ticalor 60 &Ticalor 90)
06/2021: Launched Remdesivir Injection (Remsivir)
